Accenture
ACN
$221.17
+1.18%
Accenture PLC is the world's largest professional services firm, delivering management and technology consulting, systems integration, and business process outsourcing to enterprises across financial services, health and public services, communications, media, technology, consumer goods, and resources, with roughly 814,000 employees in over 120 countries. Its scale, C-suite relationships, and vendor-agnostic delivery model make it the industry's benchmark integrator rather than a product vendor, positioning it as the primary channel through which large enterprises operationalize technology change. The current investor debate is unusually polarized: a brutal mid-2026 drawdown driven by federal contract losses and fears that generative AI will cannibalize billable consulting hours gave way to a sharp October rally after a fiscal Q4 beat and management commentary that AI-related demand is broadening into FY27 across all markets. Bulls frame Accenture as an AI transformation beneficiary with record bookings and robust cash generation, while bears argue that AI-native competitors and software-led platforms threaten the labor-arbitrage economics of traditional services — a tension now compounded by a fresh late-November selloff.…
ACN
Accenture
$221.17
Related headlines
Investment Opinion: Should I buy ACN Today?
Rating: Hold with a constructive bias. Accenture is a high-quality franchise trading at a genuine deep-value multiple — roughly 11.7x the $19.43 consensus FY EPS and 13.89x trailing earnings, versus a historical PE band of ~12.9x to 37.1x — but the analyst consensus is neutral-to-cautiously-constructive (Wells Fargo Equal Weight, Susquehanna Neutral, TD Cowen and Truist Hold, plus a Baird downgrade to Neutral on October 21), and no precise average price target is available in the provided data, so implied upside cannot be calculated. The core thesis is that the market has de-rated a 26.51% ROE, $11.62 billion FCF business to near-record-low multiples on AI cannibalization fears that the Q4 beat and management's FY27 AI-demand commentary have not yet confirmed.
Supporting evidence is strong on valuation and balance sheet: PS of 1.57x versus 6.1x at Q4 FY26 and 13.2x at Q4 FY24, EV/EBITDA of 8.32x versus the 15–20x high-quality IT services peers historically commanded, and a 1.25x PEG ratio. Cash generation is robust at $11.62 billion TTM FCF with $12.83 billion of cash, debt-to-equity of 0.42, a 1.43 current ratio, and 27.6x interest coverage, funding a 3.43% dividend at a 47.7% payout plus $2.33 billion of quarterly buybacks. Revenue grew 6.15% YoY to $18.68 billion in Q4, and the consulting ($18.70 billion) versus outsourcing ($18.73 billion) split shows a balanced book. The offset is that Q4 operating margin of 15.33% fell ~150 basis points from 16.82% a year earlier, net margin dropped to 10.66% from 12.50% in Q3, and Q4 FCF of $2.85 billion trailed the $3.60 billion and $3.67 billion of Q3 and Q2.
Three risks could invalidate the thesis: AI-native competitors and software platforms like Palantir eroding labor-arbitrage economics, continued federal contract losses extending into FY27, and discretionary consulting budget freezes hitting roughly half the revenue base. This Hold would upgrade to Buy if the stock holds the $212–$215 October breakout zone and the next print shows operating margin stabilizing near 16% with AI bookings converting to revenue; it would downgrade to Sell on a decisive break below $212 that invalidates the breakout, or if consensus EPS drifts toward the $18.97 low end. Verdict: undervalued relative to its own history and absolute peer multiples, but the discount is at least partly deserved given 6% growth and a 32% gross margin that is only average for the sector — a value opportunity awaiting confirmation, not a momentum buy.
Sign up to view all
ACN 12-Month Price Forecast
Accenture presents a classic deep-value-versus-structural-decline debate: the franchise trades at roughly 11.7x forward earnings and 1.57x sales — near the bottom of its historical band — while still generating $11.62 billion of TTM free cash flow and a 26.51% ROE, yet growth has slowed to 6.15% and Q4 operating margin fell ~150 basis points year over year. The narrow 5.3% EPS estimate spread ($18.97–$19.98) signals analysts are confident about near-term numbers but divided on the multiple, with the Hold camp outnumbering Buys after Baird's October 21 downgrade. The stock's position at ~87.9% of its 180-day range after a 25.44% three-month rally, followed by a -4.93% distribution session on 5.45 million shares, argues for patience rather than chasing. I would upgrade to bullish if the next print shows operating margin stabilizing near 16% with AI bookings converting to revenue and the $212–$215 breakout zone holding; I would downgrade to bearish on a decisive break below $212 or evidence that AI is cannibalizing rather than expanding billable work.
Wall Street consensus
Fourteen analysts cover Accenture, and the institutional ratings flow is decidedly mixed: recent actions include Goldman Sachs (Buy), Mizuho (Outperform), and RBC Capital (Outperform) on the bullish side, against Wells Fargo (Equal Weight), Susquehanna (Neutral), TD Cowen (Hold), Truist (Hold), and a notable Baird downgrade to Neutral from Outperform on October 21. The consensus leans neutral-to-cautiously-constructive rather than bullish, with the Hold camp outnumbering Buys in the visible sample. Consensus EPS estimates of $19.43 (range $18.97–$19.98) and revenue of $98.85 billion (range $97.06–$101.01 billion) imply roughly 6% growth, consistent with the recent trajectory. A precise average price target is not available in the provided data, so implied upside cannot be calculated; however, at 11.7x the $19.43 forward estimate, the stock trades at a discount that suggests the market is pricing skepticism the analyst community does not fully share. The target range is narrow on estimates — EPS spans just 5.3% from low to high ($18.97 to $19.98) and revenue spans 4.1% — signaling strong conviction in near-term numbers even as ratings diverge on valuation and AI risk. The high end of $19.98 EPS assumes AI-driven bookings convert to margin-accretive revenue and the federal contract headwind proves contained; the low end of $18.97 prices in continued pricing pressure and slower discretionary consulting spend. The Baird downgrade and the cluster of Holds around the October print suggest analysts see the post-earnings rally as having captured much of the near-term upside, and the wide dispersion in ratings — rather than in estimates — is the key signal: the debate is about multiple, not earnings.
Bulls vs Bears: ACN Investment Factors
The evidence currently favors the bear side on momentum and sentiment but the bull side on valuation and balance-sheet quality: the stock has de-rated to ~11.7x forward earnings and 1.57x sales — near the bottom of its historical band — while generating $11.62 billion of TTM free cash flow and a 26.51% ROE, yet it just broke a key support shelf on distribution volume and sits with a Hold-leaning analyst consensus after a Baird downgrade. The single most important tension is whether generative AI proves accretive to Accenture's bookings (as management's FY27 commentary suggests) or cannibalizes billable consulting hours (as the PS collapse from 13.2x to 1.57x implies the market fears). If AI is accretive, the current multiple is a generational entry point; if it is cannibalistic, 6% growth and compressing margins justify the discount. Until the next earnings print resolves this, the risk/reward is asymmetric but the timing is uncertain, and the recent -4.93% session argues for patience rather than chasing.
Bullish
- Deep value multiple vs. own history: At $227.49 the stock trades at roughly 11.7x the $19.43 consensus FY EPS and 13.89x trailing earnings, versus a historical PE band of ~12.9x (Q3 FY26) to 37.1x (Q4 FY23) and ~22–28x through 2023–2025. The PS ratio of 1.57x compares with 6.1x at Q4 FY26 and 13.2x at Q4 FY24, meaning the market has de-rated the franchise to near-record lows while earnings estimates remain intact.
- AI demand broadening into FY27: Management's Q4 call commentary that AI-related demand is broadening across all markets into FY27, combined with a fiscal Q4 beat, drove a 26.92% six-month and 25.44% three-month gain. The Q4 revenue of $18.68 billion grew 6.15% YoY and topped the prior-year $17.60 billion comparable, supporting the view that AI is additive to bookings rather than purely cannibalistic.
- Fortress balance sheet and cash generation: Free cash flow TTM is $11.62 billion, with Q4 alone generating $2.85 billion of FCF on $3.10 billion of operating cash flow. Debt-to-equity of 0.42, a 1.43 current ratio, $12.83 billion of cash, and 27.6x interest coverage mean Accenture funds growth, a 3.43% dividend (47.7% payout), and $2.33 billion of quarterly buybacks internally.
- Excellent returns and covered dividend: ROE of 26.51% is best-in-class for IT services, and the 3.43% dividend yield is comfortably covered at a 47.7% payout ratio. The 1.25x PEG ratio and 8.32x EV/EBITDA sit well below the 15–20x EV/EBITDA ranges high-quality IT services peers historically commanded.
Bearish
- Margin compression is real and directional: Q4 operating margin of 15.33% fell roughly 150 basis points from 16.82% in the prior-year Q3, and net margin of 10.66% dropped from 12.50% in Q3. A 27.3% effective tax rate versus 24.2% in Q3 helped push Q4 EPS to $3.31 from $3.82 sequentially, suggesting pricing pressure or AI investment is eroding the labor-arbitrage economics.
- AI-native competitors threaten the model: Bears argue AI-native competitors and software-led platforms threaten the billable-hours economics of traditional consulting; the Motley Fool's October piece contrasting Palantir's software-like scalability with consulting economics crystallizes this fear. The collapse in PS from 13.2x to 1.57x reflects a structural de-rating of services business models, not just a cyclical dip.
- Federal contract losses and 6% growth: The mid-2026 drawdown was driven by real federal contract losses, and 6.15% revenue growth is far from the double-digit profile that historically justified a premium multiple. Consensus revenue of $98.85 billion implies only ~6% growth, so the earnings base is not accelerating enough to quickly re-rate the stock.
- Analyst sentiment is neutral-to-cautious: Of 14 analysts, the Hold camp outnumbers Buys in the visible sample, with Wells Fargo (Equal Weight), Susquehanna (Neutral), TD Cowen (Hold), Truist (Hold), and a Baird downgrade to Neutral from Outperform on October 21. The narrow EPS range of $18.97–$19.98 (5.3% spread) signals the debate is about multiple, not earnings — and the market is winning that debate so far.
ACN Technical Analysis
Accenture is in a recovery uptrend that has stalled at the highs, with the stock down 5.21% over the past year but up 26.92% over six months and 25.44% over three months. The current price of $227.49 sits roughly 87.9% of the way through its 180-day range of $124.44 to $265.16, having more than doubled off the June low before retreating from the November 5 high. That positioning signals a stock that has reclaimed momentum but is now testing whether the rebound has run ahead of fundamentals, particularly after a -4.93% single-session drop on the latest close. Short-term momentum has clearly decelerated: the 1-month change of -3.98% conflicts with the +25.44% three-month gain, a divergence that typically flags either a healthy consolidation within a new uptrend or the early stage of a failed breakout. Relative strength tells the same story — ACN outperformed SPY by 29.69 percentage points over three months but lagged by 15.83 points over twelve months, and its 1-month relative strength of 0.75 is roughly in line with a soft tape (SPY -4.73%). Volume of 5.45 million shares on the down day suggests distribution rather than capitulation, and with no RSI provided, the magnitude of the pullback from $265 to $227 is the best available overbought-to-neutral reset signal. Key support sits at the $239–$240 shelf that broke on the latest close, with deeper support at the $212–$215 October breakout zone and the $124.44 52-week low as the line in the sand; resistance is the $265.16 high, and a decisive break above it would confirm the multi-month base and open blue-sky territory. A failure to hold $212 would invalidate the October breakout and refocus attention on the June lows. The 56.87% maximum drawdown over the period underscores how violent this name's risk profile has been, and while beta is not provided, that drawdown magnitude implies volatility well above the market — position sizing should assume wider stops than a typical large-cap services name.
Beta
—
—
Max Drawdown
-56.9%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
-8.1%
Cumulative gain past year
| Period | ACN Return | S&P 500 |
|---|---|---|
| 1m | -7.9% | -9.7% |
| 3m | +19.4% | -9.9% |
| 6m | +23.4% | -7.5% |
| 1y | -8.1% | +4.7% |
| ytd | -14.9% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACN Fundamental Analysis
Revenue is growing at a steady but unspectacular pace: fiscal Q4 (ended August 31, 2026) revenue of $18.68 billion rose 6.15% year over year, and the trailing four quarters totaled approximately $74.2 billion ($18.74B + $18.72B + $18.04B + $18.68B). The multi-quarter trend shows acceleration through the year — Q2 revenue of $18.04 billion grew from a $16.66 billion base in the prior-year Q2, while Q3's $18.72 billion and Q4's $18.68 billion each topped their year-ago comparables of $17.73 billion and $17.60 billion — implying mid-single-digit organic growth with a modest second-half pickup. Segment disclosure is thin, but the reported split of $18.70 billion consulting versus $18.73 billion outsourcing confirms a balanced book in which outsourcing now slightly exceeds consulting, consistent with clients shifting spend toward run-cost optimization and managed AI operations. The growth trajectory supports the thesis that AI demand is broadening, but 6% top-line growth is not the double-digit profile that historically justified Accenture's premium multiple. Profitability remains solid but is compressing at the margin: Q4 net income of $1.99 billion on $18.68 billion of revenue produced a 10.66% net margin, down from 12.50% in Q3 and 11.80% in the year-ago Q1, while gross margin of 32.04% was essentially flat versus 32.77% in Q3 and 31.89% a year ago. Operating margin of 15.33% in Q4 compares with 16.96% in Q3 and 16.82% in the prior-year Q3, a roughly 150-basis-point year-over-year decline that points to pricing pressure, higher delivery costs, or investment in AI capabilities. The full-year picture is better than the quarterly noise — Q1 FY26 operating margin was 16.82% and Q3 16.96% — but the Q4 dip and a 27.3% effective tax rate (versus 24.2% in Q3) explain why EPS of $3.31 lagged the $3.82 sequential print. For an IT services firm, a 32% gross margin and mid-teens operating margin are typical-to-good, but the direction of travel matters more than the level. The balance sheet is a genuine strength: debt-to-equity of 0.42, a current ratio of 1.43, and $12.83 billion of cash at period end against modest leverage. Free cash flow is robust at $11.62 billion TTM, with Q4 alone generating $2.85 billion of FCF on $3.10 billion of operating cash flow, and the company returned capital aggressively — $2.33 billion of buybacks and $974 million of dividends in Q4 alone. ROE of 26.51% is excellent for the sector, and interest coverage of 27.6x leaves ample cushion; the main caveat is that Q4 FCF of $2.85 billion was well below the $3.60 billion and $3.67 billion generated in Q3 and Q2, reflecting working-capital seasonality and $4.98 billion of debt repayment during the quarter. Net, Accenture funds growth, dividends, and buybacks internally with room to spare — financial risk is low, and the 3.43% dividend yield with a 47.7% payout ratio is comfortably covered.
Quarterly Revenue
$18.7B
2026-08
Revenue YoY Growth
+6.2%
YoY Comparison
Gross Margin
32.0%
Latest Quarter
Free Cash Flow
$11.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACN Overvalued?
Because net income is positive ($1.99 billion in Q4, ~$8.4 billion annualized), the PE ratio is the appropriate primary metric. The trailing PE of 13.89x against a forward PE of 1.25x is a data artifact — the forward figure appears to be a PEG ratio mislabeled — so the more reliable read comes from the analyst EPS estimate of $19.43 against the $227.49 price, implying roughly 11.7x forward earnings. That is remarkably cheap for a franchise of this quality, and the gap between the ~14x trailing and ~11.7x forward multiple implies the market expects meaningful EPS growth — consistent with the consensus estimate of $19.43 versus a trailing run-rate in the mid-teens. Peer comparison is constrained because the provided valuation dataset contains no industry-average multiples; on absolute terms, however, a 13.9x trailing PE, 1.57x PS, 3.68x PB, 8.32x EV/EBITDA, and 9.40x price-to-cash-flow are all well below the 20–30x PE and 15–20x EV/EBITDA ranges Accenture historically commanded and below where high-quality IT services peers typically trade. The 1.25x PEG ratio and 3.43% dividend yield reinforce the value case, though the 32% gross margin and 11.3% net margin are only average for the sector, which argues the discount is at least partly deserved rather than purely a mispricing. Historically, Accenture's own PE has ranged from roughly 12.9x (Q3 FY26) to 37.1x (Q4 FY23), with the 13.9x current reading near the very bottom of that band and far below the ~22–28x levels seen through 2023–2025. The PS ratio tells the same story: 1.57x today versus 6.1x at Q4 FY26 and 13.2x at Q4 FY24, a collapse that reflects both the share-price decline and the market's de-rating of services business models in the AI era. Near-historical-low multiples can signal either a deep value opportunity or structural deterioration — the resolution hinges on whether AI proves accretive to Accenture's bookings or cannibalizes them.
PE
13.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~37x
vs. Industry Avg
19.1x
Industry PE ~19.1x*
EV/EBITDA
8.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin compression and growth dependence rather than solvency. Q4 operating margin of 15.33% was down roughly 150 basis points year over year from 16.82%, and net margin fell to 10.66% from 12.50% in Q3, while Q4 FCF of $2.85 billion trailed the $3.60 billion and $3.67 billion generated in Q3 and Q2. Revenue growth of just 6.15% means the ~11.7x forward multiple requires steady EPS delivery, and the $4.98 billion of debt repayment in Q4 plus a 27.3% effective tax rate add quarterly earnings volatility. Concentration in discretionary consulting — $18.70 billion of the $37.4 billion quarterly book — leaves roughly half of revenue exposed to clients deferring transformation projects in a downturn.
Market and competitive risks are the dominant threat given the structural de-rating already underway. The PS ratio has collapsed from 13.2x at Q4 FY24 to 1.57x today, and the PE sits near the bottom of its 12.9x–37.1x historical band, meaning further multiple compression has limited room but a failure to re-rate leaves the stock dead money. AI-native competitors and software platforms like Palantir threaten the labor-arbitrage model, and the Baird downgrade to Neutral on October 21 plus the Hold-heavy analyst consensus (Wells Fargo, Susquehanna, TD Cowen, Truist) show institutions are not yet willing to underwrite a re-rating. With a 56.87% maximum drawdown over the period, volatility is well above a typical large-cap services name, and the -4.93% single-session drop on 5.45 million shares signals distribution risk into year-end.
In a worst-case scenario, AI cannibalization accelerates, federal contract losses extend into FY27, and discretionary consulting budgets freeze, driving consensus EPS toward the $18.97 low end and the multiple back toward the 12.9x trough — a combination that would put the stock near the $212–$215 October breakout zone and, on a full de-rating, toward the $124.44 52-week low. From the current $227.49, a retest of the 52-week low implies roughly -45%, while a break of the $212 support would invalidate the October breakout and refocus attention on the June lows. Investors should size positions assuming a realistic -20% to -45% downside in an adverse scenario, with the $239–$240 shelf now acting as overhead resistance rather than support.
FAQ
Ranked by severity: first, competitive/structural risk — AI-native platforms and software-led competitors threaten the labor-arbitrage model, a fear crystallized by the PS collapse from 13.2x to 1.57x and commentary contrasting Palantir's software economics with consulting. Second, financial/operational risk — Q4 operating margin of 15.33% fell roughly 150bp YoY from 16.82%, net margin dropped to 10.66% from 12.50% in Q3, and Q4 FCF of $2.85 billion trailed the $3.60 billion and $3.67 billion of Q3 and Q2, while 6.15% revenue growth leaves little cushion. Third, company-specific concentration — the $18.70 billion consulting book is roughly half of quarterly revenue and vulnerable to discretionary budget freezes, and federal contract losses drove the mid-2026 drawdown with risk of extending into FY27. Fourth, market/technical risk — the 56.87% maximum drawdown and the -4.93% distribution session on 5.45 million shares show volatility well above a typical large-cap services name, with a break of $212 potentially opening a path toward the $124.44 low.
The scenario framework assigns a 50% probability to the base case of $225–$265, in which Accenture delivers the consensus $19.43 EPS and $98.85 billion revenue (~6% growth), margins stabilize in the mid-teens, and the stock consolidates while holding the $212–$215 breakout zone beneath $239–$240 resistance and the $265.16 high. The bull case (30% probability, $265–$300) requires AI bookings to convert into margin-accretive revenue, federal headwinds to prove contained, and a multiple re-rating from ~11.7x toward the low-20s, retaking the November high. The bear case (20% probability, $124–$180) assumes AI cannibalization accelerates, federal losses extend into FY27, and discretionary consulting freezes, driving EPS toward the $18.97 low end and the multiple back toward the 12.9x trough. The base case is most likely, and its key assumption is that operating margin holds in the 15–17% range without further ~150bp deterioration.
On the data provided, ACN screens undervalued relative to its own history. The trailing PE of 13.89x and implied forward multiple of roughly 11.7x ($227.49 ÷ $19.43 consensus EPS) sit near the bottom of a historical band that has ranged from about 12.9x in Q3 FY26 to 37.1x in Q4 FY23, and far below the ~22–28x levels seen through 2023–2025. The PS ratio of 1.57x versus 6.1x at Q4 FY26 and 13.2x at Q4 FY24 shows how severe the de-rating has been, while EV/EBITDA of 8.32x, price-to-cash-flow of 9.40x, and a 1.25x PEG all point to a discount. The caveat is that a 32.05% gross margin and 11.28% net margin are only average for the sector, so part of the discount is deserved rather than a pure mispricing. The market is effectively pricing structural AI cannibalization of consulting hours; if that fear proves overstated, the multiple has substantial room to normalize.
The risk/reward is asymmetric but unconfirmed. On the positive side, ACN trades at roughly 11.7x the $19.43 consensus EPS and 1.57x sales — near the bottom of its historical band — while generating $11.62 billion of TTM free cash flow, a 26.51% ROE, and a 3.43% dividend covered at a 47.7% payout, with debt-to-equity of just 0.42. The downside is real: the stock fell -4.93% in a single session on 5.45 million shares to $227.49, sits below the broken $239–$240 shelf, and carries a 56.87% maximum drawdown, with a bear case that could retest the $124.44 low. Analyst sentiment is Hold-leaning (14 analysts, Baird downgraded to Neutral on October 21), and no average price target is available in the data to quantify upside. It is a good buy primarily for value-oriented investors with a multi-year horizon who want quality cash generation at a discount and can stomach a -20% to -45% adverse scenario; momentum buyers should wait for confirmation that the $212–$215 breakout zone holds.
ACN is better suited to a long-term holding period of at least two to three years than to short-term trading. The thesis depends on a multiple re-rating from ~11.7x forward earnings, which requires several quarters of evidence that AI is accretive and margins are stabilizing — a slow-burn catalyst rather than a near-term event. Volatility is high for a mega-cap: a 56.87% maximum drawdown, a -4.93% single-session drop, and a 1-month change of -3.98% against a +25.44% three-month gain mean short-term traders face whipsaw risk around the $212–$215 support and $239–$240 resistance levels. The 3.43% dividend at a 47.7% payout plus $2.33 billion of quarterly buybacks provide a modest total-return floor while waiting, and the $11.62 billion TTM FCF supports earnings visibility. A concrete minimum holding period of 24–36 months aligns with the FY27 AI-demand narrative and gives the valuation debate time to resolve.

